Table 2.
Goal | Logic for change | Strategy | Implementation plan | Mechanism of change | Agent of change | Contextual relevance |
Foster proresearch cultures | Encourages top-level investment and prioritisation of trials Encourages institutional staff and decision makers to support not hinder trials Increases pool of researchers willing and confident enough to conduct trials and reduces brain-drain |
Explain trial and research methods and potential benefits for patients, institutions and individuals |
|
Increases awareness and desire to conduct trials and top-level buy-in and support for trials |
|
Where negative research cultures or lack of interest in trials impedes operations and prevents investment Where skilled or junior staff show little inclination towards trial undertaking Where brain-drain problematic |
Provide opportunities for institutional staff to see trials conducted and practically get involved |
|
Increases awareness and desire to conduct trials. Increases motivation and self-efficacy by reducing perception that trials are difficult |
|
|||
Provide intrinsic and extrinsic incentives for employees to conduct or get involved in trials |
|
Increases motivation to conduct trials |
|
|||
Provide facilitative operational environment for trials | See section below | Increases motivation and self-efficacy to conduct trials by making trials more achievable | See section below | |||
Develop trial leaders and staff | Human resources for research are essential for increasing trial conduct, either locally or foreign led Resolving key skills gaps is needed for researchers to gain funding and conduct trials Research leaders needed to conduct trials, foster proresearch cultures, provide training and mentorship, develop new research leaders and advocate for greater investment |
Provide basic and advanced skills training. Focus on clinical trials and key skills gaps. Ensure regularity and sustainability. Best if locally applicable. |
|
Improves knowledge, develops technical skills, reinforces motivation and increase self-efficacy |
|
Where extant expertise is insufficient to meet demand Where staff have key skills gaps that prevent or impede trials Where there are insufficient research leaders Where research leaders lack leadership capabilities |
Provide practical research experiences on trials. Locally-led trials and long-term foreign partnerships usually best. |
|
Most effective technique for mastering technical skills and developing leadership capabilities. Increases motivation. |
|
|||
Provide knowledge sharing and mentorship opportunities |
|
Shares knowledge and provides support that increases knowledge, technical skills, motivation and self-efficacy |
|
|||
Provide open, easy access to knowledge resources |
|
Supports independent learning that increases knowledge and motivation |
|
|||
Provide facilitative operational environment | Reduces barriers to trial conduct that increases self-efficacy and motivation to undertake trials Makes collaboration more attractive Encourages local and foreign-led research to be conducted through local institutions Facilitates trials of greater scope and quality and increases capacity development benefits that supports advocacy for greater investments |
Provide funding for clinical trials that is sufficient to allow research of useful scope |
|
Even modest grants can enable simple but important locally led trials. Improves chances of gaining more competitive funding. |
|
Where trials are prevented due to operational barriers or material resource constraints Where operational barriers or material resources reduce the quality and scope of trials Where operational barriers or material resources prevent beneficial collaborations or capacity development |
Improve research governance and administration procedures and increase capacity to support research |
|
Speeds up trial operations and frees investigator’s time |
|
|||
Strengthen regulatory and ethical review capacity and procedures |
|
Ensures trials are safe and ethical, allows more ethically complex trials, speeds up trial operations |
|
|||
Develop material resources and infrastructure |
|
Facilitates operations and enables trials with greater scope and quality |
|
|||
Support local collaborations among research producers and stakeholders, and encourage team working |
|
Leverages resources to reach a critical mass capable of self-sufficiently undertaking trials. Improves trial operations. |
|
|||
Encourage valuable foreign partnerships. Long-term partnerships most useful |
|
Enables more resource-intensive research and helps develop local capacities |
|
|||
Ensure research is useful and has an impact | Trials must influence policy and have an impact on health outcomes for them to be considered valuable Useful and impactful trials develop and reinforce proresearch attitudes by showing benefits and returns on investments Increases credibility of locally led trials, which is needed for research leaders to advocate for further investment |
Develop and implement clear research strategy to focus investments around research priorities |
|
Ensures most efficient use of resources and builds an evidence base capable of informing policy changes |
|
Where trial evidence has limited use for policy or is not effectively disseminated Where research users lack capacity to translate research and implement policies Where poor communication and engagement impedes translation of evidence into policy |
Develop policy makers’ interest and capacity to demand and use research and implement policies |
|
Ensures research has an impact and improves patient care |
|
|||
Develop research producers interest and capacity to respond to research strategy, produce useful outputs and disseminate findings effectively |
|
Ensures research findings will be useful for policy and are effectively disseminated to influence policy |
|
|||
Increase engagement between strategists, producers and users of research |
|
Builds communication and trust between knowledge cycle actors that facilitate translation of research |
|
LMICs, low-income and middle-income countries. ICT, Information Communication Technology.